XML 51 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
Shareholders' Equity
3 Months Ended
Mar. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Shareholders' Equity

5. Shareholders’ Equity

Equity Compensation Plans

We have a stock plan (the “Stock Plan”) and an inducement stock plan for newly hired employees (the “Inducement Plan”) (collectively, the “Plans”). Under the Plans, stock options may be granted with a fixed exercise price that is equivalent to fair market value on the date of grant. These options have a term of up to 10 years and vest over a predetermined period, generally four years. Incentive stock options granted under the Stock Plan may only be granted to our employees. The Plans also allow for awards of non-qualified stock options, stock appreciation rights, RSAs and unrestricted stock awards, and RSUs.

Stock-Based Compensation

The estimated fair value of stock-based awards is recognized as compensation expense over the vesting period of the award, net of estimated forfeitures. We estimate forfeitures based on historical experience and expected future activity. The fair value of RSAs and RSUs is determined based on the number of shares granted and the quoted price of our common stock on the date of grant. The fair value of stock option awards is estimated at the grant date based on the fair value of each vesting tranche as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model. The BSM model requires various highly judgmental assumptions including expected volatility and option life. If any of the assumptions used in the BSM model change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period. The fair values of our stock option grants were estimated with the following weighted average assumptions:

 

 

Three Months Ended

March 31,

 

 

2015

 

 

2014

 

Dividend yield

 

0

%

 

 

0

%

Expected life

3.3 years

 

 

3.2 years

 

Expected volatility

 

53

%

 

 

61

%

Risk-free interest rate

 

1.2

%

 

 

1.2

%

 

The impact on our results of operations of stock-based compensation expense for the three months ended March 31, 2015 and 2014 was as follows (in thousands, except per share amounts):

 

 

Three Months Ended

March 31,

 

 

2015

 

 

2014

 

Cost of revenue — service

$

113

 

 

$

41

 

Selling, general and administrative

 

13

 

 

 

175

 

Research and development

 

138

 

 

 

28

 

Total stock-based compensation expense

$

264

 

 

$

244

 

Per diluted share

$

0.02

 

 

$

0.02

 

 

Stock Option Activity

The following table summarizes stock option activity under the Plans for the three months ended March 31, 2015:

 

Stock Options

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life

(in years)

 

 

Aggregate

Intrinsic

Value

 

Balance at January 1, 2015

 

 

1,553,360

 

 

$

3.50

 

 

 

 

 

 

 

 

 

Granted

 

 

2,500

 

 

 

4.47

 

 

 

 

 

 

 

 

 

Exercised

 

 

(28,387

)

 

 

2.97

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(45,998

)

 

 

3.20

 

 

 

 

 

 

 

 

 

Expired

 

 

(2,751

)

 

 

3.13

 

 

 

 

 

 

 

 

 

Balance at March 31, 2015

 

 

1,478,724

 

 

$

3.52

 

 

 

6.72

 

 

$

1,896,962

 

Vested and expected to vest at March 31, 2015

 

 

1,390,599

 

 

$

3.51

 

 

 

6.59

 

 

$

1,797,179

 

Exercisable at March 31, 2015

 

 

667,215

 

 

$

3.44

 

 

 

4.39

 

 

$

971,305

 

At March 31, 2015, total compensation cost related to stock options granted but not yet recognized was $661,410, net of estimated forfeitures. This cost will be amortized on the straight-line method over a weighted-average period of approximately 1.1 years. The following table summarizes certain information about stock options for the three months ended March 31, 2015 and 2014:

 

 

Three Months Ended

March 31,

 

 

2015

 

 

2014

 

Weighted-average grant-date fair value of option

   grants for the period

$

2.34

 

 

$

1.82

 

Options in-the-money at period end

 

1,353,633

 

 

 

585,885

 

Aggregate intrinsic value of options exercised

$

47,880

 

 

$

130,876

 

The aggregate intrinsic value represents the difference between the exercise price of the underlying options and the quoted price of our common stock for the number of options that were in-the-money at period end or that were exercised during the period. We issue new shares of common stock upon exercise of stock options.

Restricted Stock Unit Activity

The following table summarizes RSU activity for the three months ended March 31, 2015:

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date Fair

Value

 

Unvested at December 31, 2014

 

80,179

 

 

$

3.40

 

Granted

 

19,848

 

 

 

4.62

 

Vested

 

(24,228

)

 

 

3.32

 

Forfeited

 

(8,976

)

 

 

3.15

 

Unvested at March 31, 2015

 

66,823

 

 

$

3.82

 

Expected to vest after March 31, 2015

 

61,842

 

 

$

3.82

 

 

 

At March 31, 2015, total compensation cost related to RSUs granted but not yet recognized was $257,695, net of estimated forfeitures. This cost will be amortized on the straight-line method over a period of approximately 1.1 years.

Common Stock Reserved for Future Issuance

The following table summarizes our shares of common stock reserved for future issuance under the Plans:

 

 

March 31,

2015

 

Stock options outstanding

 

1,478,724

 

Restricted stock units outstanding

 

66,823

 

Stock awards available for future grant

 

689,460

 

Common stock reserved for future issuance

 

2,235,007